Amolyt Pharma
Delphine Martinez has extensive work experience in the pharmaceutical industry. Delphine began their career at OPi as a Trainee in 2006. After that, they joined ERYTECH Pharma in 2006 as General Counsel and Corporate Secretary, where they worked until November 2019. In December 2019, Delphine Martinez joined Amolyt Pharma as General Counsel.
Delphine Martinez has a diverse education history. Delphine pursued an Executive IMBA degree in Business Administration and Management, General from iaelyon School of Management, which they completed from 2014 to 2015. Prior to that, they earned a Master's degree in International Business Law from Université Jean Moulin (Lyon III), covering the academic year 2005 to 2006. Additionally, Delphine has not provided any specific information about their education from Euromoney, leaving it unclear whether they obtained a degree or studied in a specific field.
This person is not in any teams
Amolyt Pharma
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism.